1998
Started production of Ranitidine HCL & in short spasm of time has become one of the largest manufactured in the world
1992
Established Saraca Laboratories with an aim to manufacture Bulk Drugs & Intermediates
MILESTONES
1981
Dr. Reddy set up the flagship company Virchow Laboratories Ltd.
1995
WHO GMP, EU GMP certification
2001
Launching Bio-pharmaceutical company Virchow biotech focusing on wide range of biological & biogenetics
2001
EDQM certification. Become largest producer of Sulphamethoxazole. Servicing 90% worldwide requirement
2003
US FDA Approval
2007
First to launch indigenous generic PTH Teripartide and Interferon & Peg interferon in India
2007
Launched dedicated Advanced wound care division, Hemostats and unique SAP (Sub-atmospheric pressure) therapy
2008
Launch Virchow Healthcare Ltd. International marketing cell
2008
Signed MOU with then no.2 Pharma Company in India to market Virchow’s indigenously developed recombinant therapeutic protein for Osteoporosis treatment and Interferon, Peglitated Interferon & Ribavirin for Hepatitis management
2010
First breakthrough in CIS region
2011
Our-licensing agreement with leading pharma companies to market biotech range
2012
Launched domestic marketing arm under the banner of flagship company Virchow laboratories Ltd. With cost effective, auality solution for complete Hepatitis and Osteoporosis management
2013
Entered Latin & South America region
2015
Received PIC/S approval for plant
The journey continues...